Real-world evidence of first-line pembrolizumab plus chemotherapy in metastatic non-squamous NSCLC: A single-centre experience

被引：0
|
作者：
Bose, Subhadeep [1 ]
Khaja, Mujtaba Syed [1 ]
Siva, Asha [1 ]
Wilson, Paula [1 ]
Grist, Helen [1 ]
Murukesh, Nishanth [1 ]
机构：
[1] Worcestershire Acute Hosp NHS Trust, Worcester, W Midlands, England
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2023年 / 41卷 / 16期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
e21091
引用
收藏
页数：1
相关论文
共 50 条
  • [31] First-line pembrolizumab monotherapy for metastatic PD-L1-positive NSCLC: real-world analysis of time on treatment
    Velcheti, Vamsidhar
    Chandwani, Sheenu
    Chen, Xin
    Pietanza, M. Catherine
    Burke, Thomas
    IMMUNOTHERAPY, 2019, 11 (10) : 889 - 901
  • [32] A Real-World Study on the Effectiveness and Safety of Pembrolizumab Plus Chemotherapy for Nonsquamous NSCLC
    Fujimoto, Daichi
    Miura, Satoru
    Yoshimura, Kenichi
    Wakuda, Kazushige
    Oya, Yuko
    Haratani, Koji
    Itoh, Shoichi
    Uemura, Takehiro
    Morinaga, Ryotaro
    Takahama, Takayuki
    Nakashima, Kazuhisa
    Tachihara, Motoko
    Saito, Go
    Tanizaki, Junko
    Otsubo, Kohei
    Ikeda, Satoshi
    Matsumoto, Hirotaka
    Hara, Satoshi
    Hata, Akito
    Masuda, Takeshi
    Yamamoto, Nobuyuki
    JTO CLINICAL AND RESEARCH REPORTS, 2022, 3 (02):
  • [33] Cost-effectiveness analysis of pembrolizumab plus standard chemotherapy versus chemotherapy alone for first-line treatment of metastatic non-squamous non-small-cell lung cancer in China
    Jiang, Yuan
    Wang, Xingwei
    EUROPEAN JOURNAL OF HOSPITAL PHARMACY, 2022, 29 (03) : 139 - 144
  • [34] Real-world Efficacy and Safety of Atezolizumab Plus Bevacizumab, Paclitaxel and Carboplatin for First-line Treatment of Japanese Patients With Metastatic Non-squamous Non-small Cell Lung Cancer
    Ikeuchi, Nobumitsu
    Igata, Fumiyasu
    Kinoshita, Eriko
    Kawabata, Toshiaki
    Tan, Ibun
    Osaki, Yusuke
    Otsuka, Rikako
    On, Rintaro
    Ikeda, Takato
    Nakao, Akira
    Sasaki, Tomoya
    Aoyama, Takashi
    Hirano, Ryosuke
    Harada, Taishi
    Ebi, Noriyuki
    Fujita, Masaki
    Inoue, Hiroyuki
    ANTICANCER RESEARCH, 2023, 43 (02) : 713 - 724
  • [35] Real-World Data of Osimertinib in Patients with Metastatic EGFRm plus NSCLC who Progressed on First-Line EGFR TKIs
    Ma, J.
    Tan, S. H.
    Yin, D.
    Tran, A.
    Tan, D.
    Ang, M.
    Takano, A.
    Lim, K. H. T.
    Kanesvaran, R.
    Jain, A.
    Rajasekaran, T.
    Tan, E.
    Lim, D. W.
    Ng, Q. S.
    Tan, W.
    JOURNAL OF THORACIC ONCOLOGY, 2021, 16 (03) : S627 - S628
  • [36] REAL-WORLD TREATMENT PATTERNS AND CLINICAL OUTCOMES IN PATIENTS WITH METASTATIC NSCLC AFTER RECEIVING FIRST-LINE PEMBROLIZUMAB WITH PEMETREXED/PLATINUM CHEMOTHERAPY IN THE US ONCOLOGY NETWORK
    Goldschmidt, Jerome
    Annavarapu, Srinivas
    Venkatasetty, Divea
    Santorelli, Melissa
    Burke, Thomas
    Pennell, Nathan
    JOURNAL FOR IMMUNOTHERAPY OF CANCER, 2022, 10 : A974 - A975
  • [37] First-Line Camrelizumab Plus Chemotherapy for Advanced Non-squamous NSCLC with Brain Metastases: Updated Data from CAP-BRAIN
    Hou, X.
    Zhou, C.
    Wu, G.
    Lin, W.
    Xie, Z.
    Zhang, H.
    Yi, J.
    Peng, Z.
    Yin, L.
    Ma, C.
    Chen, L.
    JOURNAL OF THORACIC ONCOLOGY, 2023, 18 (11) : S318 - S318
  • [38] PEMETREXED IN COMBINATION WITH CISPLATIN IN THE FIRST-LINE TREATMENT OF NON-SQUAMOUS NSCLC: CZECH EXPERIENCE WITH 233 PATIENTS
    Skrickova, Jana
    Bortlicek, Zdenek
    Hejduk, Karel
    Pesek, Milos
    Kolek, Vitezslav
    Koubkova, Leona
    Roubec, Jaromir
    Tomiskova, Marcela
    Satankova, Monika
    Povolna, Zdenka
    Havel, Libor
    Coupkova, Helena
    Salajka, Frantisek
    Hrnciarik, Michal
    Zemanova, Milada
    Sixtova, Dimka
    Cernovska, Marketa
    JOURNAL OF THORACIC ONCOLOGY, 2013, 8 : S864 - S864
  • [39] Number needed to treat analysis applied to pembrolizumab plus chemotherapy for first-line treatment of non-squamous non-small cell lung cancer
    Paladini, Luciano
    Pereira da Veiga, Cassia Rita
    Cerqueira, Erica
    Haas, Laura Chabrol
    Abadi, Marcia Datz
    Baldotto, Clarissa Serodio
    JOURNAL OF MEDICAL ECONOMICS, 2021, 24 (01) : 1185 - 1193
  • [40] Clinical outcomes of first-line chemotherapy in locally advanced and metastatic pancreatic adenocarcinoma patients: Real-world experience
    Umpawan, N.
    Termsinsuk, P.
    Kaosombatwattana, U.
    Akewanlop, C.
    Korphaisarn, K.
    ANNALS OF ONCOLOGY, 2023, 34 : S919 - S920
12345